A Functional 12T-Insertion Polymorphism in the <i>ATP1A1</i> Promoter Confers Decreased Susceptibility to Hypertension in a Male Sardinian Population by Victoria L. Herrera (383897)

“…To test the effects of decreased α1Na,K-ATPase expression on blood pressure, we measured blood pressure by radiotelemetry in three month-old, highly inbred heterozygous knockout <i>ATP1A1+/−</i> male mice with resultant 58% reduction in ATP1A1 protein levels. …”

Propagation of an action potential through ephaptic coupling is achieved for a decreased extracellular conductivity. by Karoline Horgmo Jæger (6785450)

Reversion to susceptibility was consistent with decreasing relative <i>vanA</i> copy number. by Samuel E. Blechman (19506884)

Effect of iron mining tailings as a red ceramic additive for decreased sintering temperature by Igor Brumano Coelho Amaral (10472061)

Decrease in activity of transcriptional factor NRF2 in MCF-7 cells exposed to gDNA^OX at final concentrations of 50 ng/mL for 2 hours. by Svetlana V. Kostyuk (473354)

JC-1 monomer increased with the stimulation of sFlt-1 and decreased after administration of Z-LEHD-FMK in HUVECs. by Yaling Zhai (9239458)

AM251 reverses TGF-β1-dependent decreases in E-cadherin expression. by Tomoyo Yoshinaga (3391553)

TGFβ1 expression was increased, and RASAL1 expression was decreased in NTM cells in response to a hypoxic environment. by Fiona McDonnell (2636635)

“…A 0hr Control was set to 100%, and the normoxic and hypoxic results were presented as a percentage of this; Normoxic = 95.5%, Hypoxic = 159.4% (P<0.01). n = 3 *P<0.05, **P<0.01. …”

(R)-Albuterol decreases pulmonary inflammation after OVA sensitization and aerosol challenge by Marcela A Ferrada (41716)

“…</p><p></p> On the first day of OVA challenge (day 14, see Methods) a miniosmotic pump (Alzet) containing (R)- or (S)- albuterol was inserted subcutaneously (200 μg/100 μl) and delivered a constant dose of 1 mg/kg/day (25 μl/day). …”

Inflammatory Adipokines Decrease Expression of Two High Molecular Weight Isoforms of Tropomyosin Similar to the Change in Type 2 Diabetic Patients by Stuart A. Savill (3129060)

“…The change in expression in HMW isoforms from TPM1 and TPM4 was replicated in THP1 cells treated with 1 ng/ml TNFα (0.10 and 0.12 v 1.00 respectively) or 10 ng/ml IL-1α (0.17 and 0.14 v 1.00 respectively). …”

Coverage of reference gene panel by assay A to E for reference samples. by Lizhi Yu (12476136)

Subjects:

Decreased THBS1 Protein Levels Translate into Reduced TGF-β Activity by Mark A Samols (30415)

Immunoblotting for insulin sensitivity markers. by Dwight D. Harris (14484648)

Subjects:

Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)

Subjects:

Immunoblotting for JAK, STAT, and SMAD. by Dwight D. Harris (14484648)

Subjects:

Fibrosis and TUNEL staining. by Dwight D. Harris (14484648)

Subjects:

Fibrosis markers. by Dwight D. Harris (14484648)

Subjects:

Immunoblotting FOXO1 and insulin receptors. by Dwight D. Harris (14484648)

Subjects:

MiR-132-3p was downregulated in TGF-<i>β</i>1 stimulated Met-5A cells and miR-132-3p mimics and miR-132-3p inhibitor transfected Met-5A cells. by Yangyang Yin (14323701)

Subjects:

Conditional stabilization of β-catenin decreases frequency of Tbr2-expressing cells. by Christopher A. Mutch (243132)

“…This analysis also resulted in a markedly decreased Tbr2+ intermediate progenitor population in cortices (<b>F</b>) when compared to NesCre- control. …”